Yangli Qi

Title: Yangli Qi: Innovator in Pharmaceutical Compounds

Introduction

Yangli Qi is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of mental health disorders. His work is characterized by a focus on innovative chemical formulations that have practical applications in medicine.

Latest Patents

Yangli Qi holds a patent for a pyridinyl morpholine compound, which includes a preparation method and its applications. The patent describes a compound represented by a specific formula, along with its pharmaceutically acceptable salts and hydrates. This compound serves as an antagonist for one or more of D, Dor 5-HT, and is intended for use in developing drugs to treat schizophrenia. This innovation highlights his commitment to addressing critical health issues through scientific research.

Career Highlights

Throughout his career, Yangli Qi has worked with prominent organizations in the pharmaceutical industry. He has been associated with Shanghai Zhongze Therapeutics Co., Ltd. and the Shanghai Institute of Pharmaceutical Industry. His experience in these institutions has allowed him to refine his expertise and contribute to significant advancements in drug development.

Collaborations

Yangli Qi has collaborated with esteemed colleagues, including Jianqi Li and Xiaowen Chen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical sector.

Conclusion

Yangli Qi's contributions to the field of pharmaceuticals, particularly through his patented innovations, demonstrate his dedication to improving mental health treatment options. His work continues to inspire future advancements in drug development.